5 Key Takeaways

• 1

  The AGA announced new strategies to improve care for patients with inflammatory bowel disease (IBD).

• 2

  Collaboration among healthcare practitioners, insurers, pharmaceutical companies, and policymakers is essential for overcoming care barriers.

• 3

  The AGA's 12-point plan includes tailoring IBD therapy to individual patient needs and addressing insurance-related barriers.

• 4

  The plan emphasizes the importance of holistic, patient-centered multidisciplinary care that is covered by insurance.

• 5

  The AGA aims to engage pharmaceutical partners to create equitable programs that reduce prohibitive drug costs.